gastric cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Voluntarily sign an informed consent form. 2. Age = 18 years old. 3. Gastric cancer patients who are highly suspected or diagnosed through gastroscopy or routine imaging examination, with pathological types including adenocarcinoma, signet ring cell carcinoma, and low adhesion carcinoma. According to the doctor's assessment, the estimated survival period is 3 months. 5. Agree to implement strict contraception for at least 28 days after administration of 68Ga-FAPI-04. Willing and able to follow the research protocol.
Exclusion criteria
Exclusion criteria: Patients diagnosed with other malignant tumors in the past year. 2. Patients diagnosed with other pathological types of gastric cancer or other gastric malignancies during follow-up. 3. Patients who are known to be allergic to contrast-enhanced CT contrast agents and cannot undergo contrast-enhanced CT examination due to renal dysfunction or other reasons. 4. Patients undergoing any anti-tumor treatment between enhanced CT and 68Ga-FAPI-04 PET/CT examination. 5. Pregnant or lactating women. 6. Unable to cooperate with lying on the PET/CT scanning bed during the scanning period or intolerant to PET examination. 7. Patients who have received or are currently receiving radiotherapy, chemotherapy, immunotherapy, or molecular targeted therapy. 8. Have participated in other intervention clinical trials within the previous month of screening. 9. Patients who have been lost to follow-up. 10. According to the evaluation of the researchers, the subjects may have other circumstances that may affect the study or are not suitable for participation in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SUVmax;TBR;SUVmean; | — |
Secondary
| Measure | Time frame |
|---|---|
| TP;FP;FN;TN; | — |
Countries
China
Contacts
the First Affiliated Hospital of the People's Liberation Army Air Force Military Medical University